VRDN Stock Analysis: Buy, Sell, or Hold?
VRDN - Viridian Therapeutics, Inc. Common Stock
$33.00
-0.57 (-1.70%)
▼
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When VRDN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called VRDN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: VRDN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: VRDN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: VRDN is currently trading at $33.00, which is considered slightly high relative to its 30-day fair value range of $31.09 to $33.20.
Technical Outlook: Technically, VRDN is in a strong uptrend. Immediate support is located at $31.26, while resistance sits at $34.20.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.88 (+24.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VRDN is in a strong uptrend. Immediate support is located at $31.26, while resistance sits at $34.20.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.88 (+24.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$31.09 -
$33.20
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.8%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 24.8% below Wall St target ($41.88)
Fair Price Analysis
30-Day Fair Range
$31.09 -
$33.20
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$31.26
Resistance Level
$34.20
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-9.40
Wall Street Target
$41.88
(+24.8%)
Revenue Growth (YoY)
81958.1%
Last updated: January 31, 2026 5:41 AM ET
Data refreshes hourly during market hours. Next update: 6:41 AM
Data refreshes hourly during market hours. Next update: 6:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VRDN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$273 | 59 HOLD |
Advanced VRDN Option Strategies
Professional options setups generated by AI based on today's VRDN price and gamma walls.
